LOGIN  |  REGISTER

Recent Insider Transactions

Company
Name / Role
Date
Type
Price
# Shares
Value
Balance
NASDAQ ABEO Abeona Therapeutics
Alvino Mark / director
01/21/2025
Sell
$5.10
4,000
$20K
68,334
NASDAQ ACCD Accolade
SINGH RAJEEV / director, officer: Chief Executive Officer
01/17/2025
Sell
$6.86
309
$2K
820,211
NASDAQ ACCD Accolade
Cavanaugh Robert N / officer: President
01/17/2025
Sell
$6.86
186
$1K
215,089
NASDAQ ACCD Accolade
Barnes Stephen H. / officer: Chief Financial Officer
01/17/2025
Sell
$6.86
154
$1K
222,244
NASDAQ ADAP Adaptimmune Therapeutics
Rawcliffe Adrian / director, officer: Chief Executive Officer
01/17/2025
Sell
$0.58
30,601
$18K
44,327
NASDAQ ADAP Adaptimmune Therapeutics
Norry Elliot / officer: Chief Medical Officer
01/13/2025
Sell
$0.59
4,268
$3K
5,845
NASDAQ ADAP Adaptimmune Therapeutics
Bertrand William C JR / officer: Chief Operating Officer
01/13/2025
Sell
$0.59
5,471
$3K
7,623
NASDAQ ADAP Adaptimmune Therapeutics
Rawcliffe Adrian / director, officer: Chief Executive Officer
01/13/2025
Sell
$0.59
12,539
$7K
17,801
NASDAQ ADAP Adaptimmune Therapeutics
Bertrand William C JR / officer: Chief Operating Officer
01/17/2025
Sell
$0.58
5,584
$3K
7,510
NASDAQ ADAP Adaptimmune Therapeutics
Norry Elliot / officer: Chief Medical Officer
01/13/2025
Sell
$0.59
8,124
$5K
11,516
NASDAQ ADAP Adaptimmune Therapeutics
Bertrand William C JR / officer: Chief Operating Officer
01/15/2025
Sell
$0.57
9,803
$6K
13,756
NASDAQ ADAP Adaptimmune Therapeutics
Rawcliffe Adrian / director, officer: Chief Executive Officer
01/13/2025
Sell
$0.59
17,934
$11K
25,711
NASDAQ ADAP Adaptimmune Therapeutics
Norry Elliot / officer: Chief Medical Officer
01/15/2025
Sell
$0.57
9,803
$6K
13,756
NASDAQ ADAP Adaptimmune Therapeutics
Rawcliffe Adrian / director, officer: Chief Executive Officer
01/15/2025
Sell
$0.57
29,096
$17K
41,582
NASDAQ ADAP Adaptimmune Therapeutics
Lunger John / officer: Chief Patient Supply Officer
01/17/2025
Sell
$0.58
5,584
$3K
7,510
NASDAQ ADAP Adaptimmune Therapeutics
Lunger John / officer: Chief Patient Supply Officer
01/13/2025
Sell
$0.59
4,268
$3K
5,845
NASDAQ ADAP Adaptimmune Therapeutics
Norry Elliot / officer: Chief Medical Officer
01/17/2025
Sell
$0.58
5,584
$3K
7,510
NASDAQ ADAP Adaptimmune Therapeutics
Lunger John / officer: Chief Patient Supply Officer
01/13/2025
Sell
$0.59
5,471
$3K
7,623
NASDAQ ADAP Adaptimmune Therapeutics
Lunger John / officer: Chief Patient Supply Officer
01/15/2025
Sell
$0.57
9,803
$6K
13,756
NASDAQ ADAP Adaptimmune Therapeutics
Bertrand William C JR / officer: Chief Operating Officer
01/13/2025
Sell
$0.59
4,268
$3K
5,845
NASDAQ ADAP Adaptimmune Therapeutics
Piccina Cintia / officer: Chief Commercial Officer
01/15/2025
Sell
$0.57
12,991
$7K
18,421
NASDAQ ANIX Anixa Biosciences
Catelani Michael / officer: President, COO, & CFO
01/15/2025
Buy
$2.15
9,289
$20K
44,500
NASDAQ ANIX Anixa Biosciences
KUMAR AMIT / officer: Chief Executive Officer
01/15/2025
Buy
$2.23
43,000
$96K
559,925
NASDAQ ANIX Anixa Biosciences
Titterton Lewis H jr / director
01/21/2025
Buy
$2.59
6,000
$16K
928,334
NASDAQ APLS Apellis Pharmaceuticals
Lewis Karen / officer: Chief People Officer
01/17/2025
Sell
$29.96
1,241
$37K
43,858
NASDAQ APLS Apellis Pharmaceuticals
DeLong Mark Jeffrey / officer: Chief Business & Strat Officer
01/17/2025
Sell
$29.96
1,235
$37K
57,561
NASDAQ APLS Apellis Pharmaceuticals
Nicholson Nur / officer: Chief Technical Officer
01/17/2025
Sell
$29.96
2,145
$64K
52,011
NASDAQ APLS Apellis Pharmaceuticals
Sullivan Timothy Eugene / officer: Chief Financial Officer
01/17/2025
Sell
$29.96
1,730
$52K
86,370
NASDAQ APLS Apellis Pharmaceuticals
Townsend Adam J. / officer: Chief Commercial Officer
01/17/2025
Sell
$29.96
2,201
$66K
88,068
NASDAQ APLS Apellis Pharmaceuticals
Deschatelets Pascal / officer: Chief Scientific Officer
01/17/2025
Sell
$29.96
750
$22K
1.14M
NASDAQ APLS Apellis Pharmaceuticals
Watson David O. / officer: General Counsel
01/17/2025
Sell
$29.96
2,201
$66K
105,555
NASDAQ APLS Apellis Pharmaceuticals
Baumal Caroline / officer: Chief Medical Officer
01/17/2025
Sell
$29.96
1,853
$56K
53,707
NASDAQ APLS Apellis Pharmaceuticals
Francois Cedric / director, officer: Chief Executive Officer
01/17/2025
Sell
$29.96
6,007
$180K
301,408
NASDAQ APLS Apellis Pharmaceuticals
Chopas James George / officer: VP/Chief Accounting Officer
01/17/2025
Sell
$29.96
715
$21K
36,643
NASDAQ ACLX Arcellx
Patel Kavita / director
01/14/2025
Sell
$67.32
300
$20K
0
NASDAQ ACLX Arcellx
Patel Kavita / director
01/14/2025
Sell
$66.62
400
$27K
300
NASDAQ ACLX Arcellx
Patel Kavita / director
01/14/2025
Sell
$64.95
800
$52K
700
NASDAQ AVIR Atea Pharmaceuticals
BERGER FRANKLIN M / director
01/15/2025
Sell
$3.19
15,000
$48K
466,897
NASDAQ AVIR Atea Pharmaceuticals
BERGER FRANKLIN M / director
01/16/2025
Sell
$3.36
10,000
$34K
476,897
NASDAQ AURA Aura Biosciences
Elazzouzi Amy / officer: Vice President, Finance
01/21/2025
Sell
$7.67
1,001
$8K
38,442
NASDAQ AURA Aura Biosciences
de los Pinos Elisabet / director, officer: See Remarks
01/21/2025
Sell
$7.67
15,955
$122K
304,692
NYSE BDX Becton Dickinson
Shan David / officer: EVP and Chief ISC Officer
01/21/2025
Sell
$240.00
500
$120K
5,741
NYSE BDX Becton Dickinson
Garrison Michael David / officer: EVP & President, Medical
01/17/2025
Sell
$236.51
597
$141K
5,544
NYSE BDX Becton Dickinson
Neal Shana Carol / officer: EVP and Chief People Officer
01/21/2025
Sell
$240.00
787
$189K
15,414
NASDAQ BVS Bioventus
Claypoole Robert E / director, officer: President and CEO
01/13/2025
Sell
$9.10
28,786
$262K
64,964
NASDAQ CADL Candel Therapeutics
Nichols William Garrett / officer: Chief Medical Officer
01/15/2025
Sell
$7.23
10,428
$75K
79,320
NASDAQ CADL Candel Therapeutics
Tak Paul Peter / director, officer: Chief Executive Officer
01/15/2025
Sell
$7.23
21,704
$157K
251,912
NASDAQ CADL Candel Therapeutics
Schoch Charles / officer: See Remarks
01/15/2025
Sell
$7.23
9,511
$69K
43,038
NASDAQ CADL Candel Therapeutics
Tyagarajan Seshu / officer: Chief Technology Officer
01/15/2025
Sell
$7.23
14,322
$103K
96,790
NASDAQ CADL Candel Therapeutics
Barone Francesca / officer: Chief Scientific Officer
01/15/2025
Sell
$7.23
13,534
$98K
110,673
NASDAQ RNAC Cartesian Therapeutics
SPRINGER TIMOTHY A / director, 10 percent owner:
01/13/2025
Buy
$16.86
7,962
$134K
8.52M
NASDAQ RNAC Cartesian Therapeutics
SPRINGER TIMOTHY A / director, 10 percent owner:
01/13/2025
Buy
$17.78
8,983
$160K
8.53M
NASDAQ RNAC Cartesian Therapeutics
SPRINGER TIMOTHY A / director, 10 percent owner:
01/14/2025
Buy
$18.00
4,022
$72K
8.53M
NASDAQ CNTA Centessa Pharmaceuticals
HUSSAIN IQBAL J / officer: General Counsel
01/15/2025
Sell
$15.29
6,000
$92K
118,265
NASDAQ COGT Cogent Biosciences
Pinnow Cole / officer: Chief Commercial Officer
01/14/2025
Buy
$7.60
43,750
$332K
45,848
NASDAQ CORT Corcept Therapeutics
Swisher Daniel N JR / director
01/10/2025
Sell
$50.54
2,200
$111K
0
NASDAQ COSM Cosmos Health
Siokas Grigorios / director, 10 percent owner, officer: Chief Executive Officer
01/14/2025
Buy
$0.69
87,247
$60K
4.03M
NASDAQ COSM Cosmos Health
Siokas Grigorios / director, 10 percent owner, officer: Chief Executive Officer
01/16/2025
Buy
$0.84
47,904
$40K
4.14M
NASDAQ COSM Cosmos Health
Siokas Grigorios / director, 10 percent owner, officer: Chief Executive Officer
01/17/2025
Buy
$0.86
29,158
$25K
4.16M
NASDAQ COSM Cosmos Health
Siokas Grigorios / director, 10 percent owner, officer: Chief Executive Officer
01/15/2025
Buy
$0.80
62,500
$50K
4.09M
NASDAQ CYTK Cytokinetics
Malik Fady Ibraham / officer: EVP Research & Development
01/21/2025
Sell
$45.92
2,000
$92K
116,071
NYSE EW Edwards Lifesciences
Lippis Daniel J. / officer: CVP, JAPAC
01/16/2025
Sell
$68.76
500
$34K
23,189
NYSE EW Edwards Lifesciences
BOBO DONALD E JR / officer: CVP,Strategy/Corp Development
01/16/2025
Sell
$68.75
5,000
$344K
46,935
NASDAQ FTRE Fortrea
Pike Thomas / director, officer: Chief Executive Officer
01/13/2025
Sell
$18.04
11,268
$203K
159,868
NASDAQ GILD Gilead Sciences
Dickinson Andrew D / officer: Chief Financial Officer
01/15/2025
Sell
$91.35
2,500
$228K
129,873
NASDAQ GYRE Gyre Therapeutics
Ma Songjiang / director, officer: President
01/15/2025
Sell
$10.85
2,000
$22K
2.91M
NASDAQ GYRE Gyre Therapeutics
Ma Songjiang / director, officer: President
01/17/2025
Sell
$10.72
2,000
$21K
2.91M
NASDAQ GYRE Gyre Therapeutics
Ma Songjiang / director, officer: President
01/14/2025
Sell
$10.39
2,000
$21K
2.91M
NASDAQ GYRE Gyre Therapeutics
Ma Songjiang / director, officer: President
01/16/2025
Sell
$10.71
2,000
$21K
2.91M
NASDAQ HRMY Harmony Biosciences
Dierks Jeffrey / officer: CHIEF COMMERCIAL OFFICER
01/21/2025
Sell
$40.00
1,123
$45K
0
NASDAQ HRMY Harmony Biosciences
Dierks Jeffrey / officer: CHIEF COMMERCIAL OFFICER
01/16/2025
Sell
$37.41
29,475
$1.103M
0
NASDAQ HRMY Harmony Biosciences
Dierks Jeffrey / officer: CHIEF COMMERCIAL OFFICER
01/15/2025
Sell
$37.01
10,507
$389K
0
NASDAQ HRMY Harmony Biosciences
Dierks Jeffrey / officer: CHIEF COMMERCIAL OFFICER
01/13/2025
Sell
$37.04
7,180
$266K
0
NASDAQ HCAT Health Catalyst
Llewelyn Linda / officer: Chief People Officer
01/15/2025
Sell
$5.80
6,442
$37K
92,260
NASDAQ IGMS IGM Biosciences
Weber Steven / officer: PRINCIPAL ACCOUNTING OFFICER
01/15/2025
Sell
$1.70
1,122
$2K
30,582
NASDAQ IONS Ionis Pharmaceuticals
BENNETT C FRANK / officer: EVP, Chief Scientific Officer
01/16/2025
Sell
$32.90
6,752
$222K
90,866
NASDAQ IONS Ionis Pharmaceuticals
O'NEIL PATRICK R. / officer: EVP CLO & General Counsel
01/16/2025
Sell
$32.83
7,360
$242K
61,203
NASDAQ IONS Ionis Pharmaceuticals
Birchler Brian / officer: EVP, Corp and Development Ops
01/16/2025
Sell
$32.70
5,400
$177K
55,051
NASDAQ IONS Ionis Pharmaceuticals
Schneider Eugene / officer: EVP, Chf Clinical Develop Ofcr
01/16/2025
Sell
$32.79
6,523
$214K
58,508
NASDAQ IONS Ionis Pharmaceuticals
Devers Shannon L. / officer: EVP, Chief Human Resources Ofc
01/16/2025
Sell
$32.78
4,267
$140K
15,937
NASDAQ IONS Ionis Pharmaceuticals
Swayze Eric / officer: EVP Research
01/16/2025
Sell
$32.70
22
$719
184
NASDAQ IONS Ionis Pharmaceuticals
Geary Richard S / officer: EVP, Chief Development Officer
01/16/2025
Sell
$32.86
7,072
$232K
96,663
NASDAQ IONS Ionis Pharmaceuticals
Swayze Eric / officer: EVP Research
01/16/2025
Sell
$32.84
7,154
$235K
45,670
NASDAQ IONS Ionis Pharmaceuticals
Baroldi Joseph / officer: EVP, Chief Business Officer
01/16/2025
Sell
$32.70
1,029
$34K
3,071
NASDAQ IONS Ionis Pharmaceuticals
HOUGEN ELIZABETH L / officer: EVP, Finance & CFO
01/16/2025
Sell
$32.81
8,870
$291K
107,885
NASDAQ IONS Ionis Pharmaceuticals
Baroldi Joseph / officer: EVP, Chief Business Officer
01/16/2025
Sell
$32.70
3,401
$111K
25,017
NASDAQ IONS Ionis Pharmaceuticals
Monia Brett P / director, officer: Chief Executive Officer
01/16/2025
Sell
$32.63
33,445
$1.091M
207,396
NASDAQ LNTH Lantheus
Thrall James H / director
01/15/2025
Sell
$94.76
1,000
$95K
33,207
NASDAQ MDGL Madrigal Pharmaceuticals
Kelley Shannon T / officer: General Counsel
01/17/2025
Sell
$273.41
277
$76K
7,705
NASDAQ MDGL Madrigal Pharmaceuticals
Taub Rebecca / director, officer: Pres., R&D, and CMO
01/17/2025
Sell
$273.41
1,689
$462K
457,310
NASDAQ MDGL Madrigal Pharmaceuticals
Waltermire Robert E. / officer: Senior VP, Chief Pharma Dev.
01/17/2025
Sell
$273.41
442
$121K
5,058
TSX.V MRVL Marvel Biosciences
Meintjes Willem A / officer: Chief Financial Officer
01/15/2025
Sell
$118.33
1,500
$177K
111,211
TSX.V MRVL Marvel Biosciences
Casper Mark / officer: EVP & Chief Legal Officer
01/17/2025
Sell
$123.08
7,755
$954K
0
NASDAQ MGTX MeiraGTx
Giroux Richard / officer: CFO & COO
01/21/2025
Sell
$6.29
24,000
$151K
849,947
NASDAQ MRSN Mersana Therapeutics
Lowinger Timothy B / officer: SVP, Chief Sci.&Tech. Officer
01/16/2025
Sell
$0.58
8,048
$5K
257,673
NASDAQ MRSN Mersana Therapeutics
Carvajal Alejandra / officer: SVP, Chief Legal Officer
01/14/2025
Sell
$0.66
3,330
$2K
69,344
NASDAQ MRSN Mersana Therapeutics
Carvajal Alejandra / officer: SVP, Chief Legal Officer
01/15/2025
Sell
$0.63
952
$600
70,892
NASDAQ MRSN Mersana Therapeutics
Protopapas Anna / director
01/16/2025
Sell
$0.58
8,637
$5K
168,041
NASDAQ MRSN Mersana Therapeutics
DeSchuytner Brian / officer: SVP, COO & CFO
01/14/2025
Sell
$0.66
3,713
$2K
105,111
NASDAQ MRSN Mersana Therapeutics
Bala Mohan / officer: SVP, Chief Development Officer
01/16/2025
Sell
$0.58
5,939
$3K
68,872
NASDAQ MRSN Mersana Therapeutics
DeSchuytner Brian / officer: SVP, COO & CFO
01/15/2025
Sell
$0.63
2,331
$1K
109,030
NASDAQ MRSN Mersana Therapeutics
Mandelia Ashish / officer: VP, Chief Accounting Officer
01/16/2025
Sell
$0.58
3,554
$2K
57,519
NASDAQ MRSN Mersana Therapeutics
Lowinger Timothy B / officer: SVP, Chief Sci.&Tech. Officer
01/14/2025
Sell
$0.66
3,483
$2K
242,932
NASDAQ MRSN Mersana Therapeutics
Carvajal Alejandra / officer: SVP, Chief Legal Officer
01/16/2025
Sell
$0.58
5,096
$3K
78,296
NASDAQ MRSN Mersana Therapeutics
Lowinger Timothy B / officer: SVP, Chief Sci.&Tech. Officer
01/15/2025
Sell
$0.63
1,794
$1K
245,930
NASDAQ MRSN Mersana Therapeutics
Mandelia Ashish / officer: VP, Chief Accounting Officer
01/14/2025
Sell
$0.66
1,007
$665
49,396
NASDAQ MRSN Mersana Therapeutics
DeSchuytner Brian / officer: SVP, COO & CFO
01/16/2025
Sell
$0.58
8,470
$5K
121,393
NASDAQ MRSN Mersana Therapeutics
Mandelia Ashish / officer: VP, Chief Accounting Officer
01/15/2025
Sell
$0.63
1,791
$1K
52,388
NASDAQ MRSN Mersana Therapeutics
Protopapas Anna / director
01/15/2025
Sell
$0.63
6,191
$4K
155,428
NASDAQ MRSN Mersana Therapeutics
Protopapas Anna / director
01/14/2025
Sell
$0.66
11,534
$8K
144,869
NASDAQ MRSN Mersana Therapeutics
Huber Martin H. Jr. / director, officer: President, CEO
01/16/2025
Sell
$0.58
4,514
$3K
122,875
NASDAQ MRSN Mersana Therapeutics
Bala Mohan / officer: SVP, Chief Development Officer
01/14/2025
Sell
$0.66
3,253
$2K
60,228
NASDAQ MLYS Mineralys Therapeutics
Congleton Jon / director, officer: Chief Executive Officer
01/13/2025
Sell
$9.06
18,333
$166K
877,608
NASDAQ MLYS Mineralys Therapeutics
Levy Adam Scott / officer: CFO and Secretary
01/13/2025
Sell
$9.63
100
$963
226,097
NASDAQ MLYS Mineralys Therapeutics
Levy Adam Scott / officer: CFO and Secretary
01/13/2025
Sell
$9.09
10,657
$97K
226,197
NASDAQ MIRM Mirum Pharmaceuticals
Quan Joanne / officer: CHIEF MEDICAL OFFICER
01/17/2025
Sell
$45.86
6,969
$320K
5,649
NASDAQ MODV ModivCare
Coliseum Capital Management, LLC / 10 percent owner
01/10/2025
Buy
$7.91
120,237
$951K
3.68M
NASDAQ MODV ModivCare
Coliseum Capital Management, LLC / 10 percent owner
01/10/2025
Buy
$8.79
26,326
$231K
3.70M
NASDAQ MODV ModivCare
Coliseum Capital Management, LLC / 10 percent owner
01/13/2025
Buy
$6.56
452,378
$2.968M
4.16M
NASDAQ MODV ModivCare
Coliseum Capital Management, LLC / 10 percent owner
01/14/2025
Buy
$5.88
330,046
$1.941M
4.49M
NASDAQ MODV ModivCare
Coliseum Capital Management, LLC / 10 percent owner
01/10/2025
Buy
$6.81
573,437
$3.905M
3.56M
NASDAQ NEOG Neogen
ADENT JOHN EDWARD / officer: CEO
01/16/2025
Buy
$11.03
23,035
$254K
269,164
NASDAQ NEOG Neogen
Naemura David H. / officer: CFO
01/16/2025
Buy
$11.11
14,800
$164K
61,434
NASDAQ NBIX Neurocrine Biosciences
Gano Kyle / director, officer: Chief Executive Officer
01/15/2025
Sell
$141.50
4,812
$681K
135,392
NASDAQ NBIX Neurocrine Biosciences
Gano Kyle / director, officer: Chief Executive Officer
01/15/2025
Sell
$141.50
60,188
$8.517M
135,392
NASDAQ NVCR Novocure
Paravasthu Mukund / officer: Chief Operating Officer
01/11/2025
Sell
$26.81
2,160
$58K
31,437
NASDAQ OFIX Orthofix Medical
Andrews Julie / officer: CFO
01/16/2025
Sell
$17.89
4,655
$83K
28,312
NYSEAMEX OSTX OS Therapies
Auerbach Shalom / 10 percent owner
01/15/2025
Sell
$6.74
16,720
$113K
2.53M
NYSE OWLT Owlet
Harris Jonathan / officer: President & CRO
01/16/2025
Sell
$4.30
7,740
$33K
280,877
NYSE OWLT Owlet
Harris Jonathan / officer: President & CRO
01/07/2025
Sell
$4.45
16,439
$73K
288,617
NYSE OWLT Owlet
Crawford Amanda / officer: Chief Financial Officer
01/16/2025
Sell
$4.30
182
$783
150,508
NYSE PHR Phreesia
Hoffman Allison C / officer: General Counsel & Secretary
01/15/2025
Sell
$26.98
1,089
$29K
154,552
NYSE PHR Phreesia
Roberts Evan / officer: Chief Operating Officer
01/15/2025
Sell
$26.98
1,785
$48K
768,208
NYSE PHR Phreesia
Hoffman Allison C / officer: General Counsel & Secretary
01/15/2025
Sell
$26.87
3,496
$94K
155,641
NYSE PHR Phreesia
Linetsky David / officer: SVP, Life Sciences
01/15/2025
Sell
$26.98
1,946
$53K
237,265
NYSE PHR Phreesia
Hui Yvonne / officer: Principal Accounting Officer
01/15/2025
Sell
$26.87
381
$10K
25,774
NYSE PHR Phreesia
Hui Yvonne / officer: Principal Accounting Officer
01/14/2025
Sell
$26.38
362
$10K
26,155
NYSE PHR Phreesia
VanDuyn Amy Beth / officer: SVP, Human Resources
01/15/2025
Sell
$26.98
604
$16K
115,029
NYSE PHR Phreesia
Indig Chaim / director, officer: Chief Executive Officer
01/15/2025
Sell
$26.98
2,990
$81K
1.26M
NYSE PHR Phreesia
Gandhi Balaji / officer: Chief Financial Officer
01/15/2025
Sell
$26.98
836
$23K
147,673
NASDAQ PDEX Pro-Dex
CABILLOT RAYMOND E / director, 10 percent owner:
01/10/2025
Sell
$47.76
1,200
$57K
359,646
NASDAQ PDEX Pro-Dex
CABILLOT RAYMOND E / director, 10 percent owner:
01/15/2025
Sell
$45.18
1,879
$85K
352,996
NASDAQ PDEX Pro-Dex
CABILLOT RAYMOND E / director, 10 percent owner:
01/14/2025
Sell
$45.18
1,147
$52K
354,875
NASDAQ PDEX Pro-Dex
CABILLOT RAYMOND E / director, 10 percent owner:
01/13/2025
Sell
$46.66
3,624
$169K
356,022
NASDAQ LUNG Pulmonx
French Glendon E. III / director
01/16/2025
Sell
$6.53
2,326
$15K
1.07M
NASDAQ LUNG Pulmonx
French Glendon E. III / director
01/17/2025
Sell
$6.50
2,221
$14K
1.07M
NYSEAMEX RVP Retractable Technologies
SHAW THOMAS J / director, 10 percent owner, officer: PRESIDENT AND CEO
01/14/2025
Buy
$0.74
11,547
$9K
14.98M
NASDAQ RXST RxSight
Corley Jesse Anderson / director
01/15/2025
Buy
$31.19
1,443
$45K
1,443
NASDAQ RXST RxSight
Corley Jesse Anderson / director
01/16/2025
Buy
$31.13
1,767
$55K
3,210
NASDAQ SERA Sera Prognostics
Kearney Paul / officer: Chief Data Officer
01/10/2025
Sell
$8.06
1,144
$9K
163,470
NASDAQ SERA Sera Prognostics
Phillips Joshua / director
01/10/2025
Sell
$7.18
1,881
$14K
4,872
NASDAQ SERA Sera Prognostics
Jackson Benjamin / officer: General Counsel
01/13/2025
Sell
$6.38
7,912
$50K
120,561
NASDAQ SERA Sera Prognostics
Phillips Joshua / director
01/10/2025
Sell
$7.18
2
$14
6
NASDAQ SERA Sera Prognostics
Kearney Paul / officer: Chief Data Officer
01/10/2025
Sell
$7.36
12,275
$90K
164,614
NASDAQ SERA Sera Prognostics
Phillips Joshua / director
01/10/2025
Sell
$8.03
921
$7K
6,153
NASDAQ SERA Sera Prognostics
Jackson Benjamin / officer: General Counsel
01/10/2025
Sell
$8.05
1,231
$10K
128,473
NASDAQ SERA Sera Prognostics
Phillips Joshua / director
01/13/2025
Sell
$6.39
2,415
$15K
1,814
NASDAQ SERA Sera Prognostics
Harrison Robert Gardner / officer: Chief Information Officer
01/13/2025
Sell
$6.47
2,264
$15K
114,573
NASDAQ SERA Sera Prognostics
Jackson Benjamin / officer: General Counsel
01/10/2025
Sell
$7.36
12,041
$89K
129,704
NASDAQ SERA Sera Prognostics
Phillips Joshua / director
01/10/2025
Sell
$7.18
2,692
$19K
7,074
NASDAQ SERA Sera Prognostics
Phillips Joshua / director
01/13/2025
Sell
$6.39
3,458
$22K
2,695
NASDAQ SERA Sera Prognostics
Phillips Joshua / director
01/14/2025
Sell
$6.29
2,695
$17K
0
NASDAQ SERA Sera Prognostics
Harrison Robert Gardner / officer: Chief Information Officer
01/10/2025
Sell
$8.01
1,837
$15K
116,837
NASDAQ SERA Sera Prognostics
Phillips Joshua / director
01/10/2025
Sell
$8.03
1,674
$13K
11,114
NASDAQ SERA Sera Prognostics
Phillips Joshua / director
01/10/2025
Sell
$8.03
643
$5K
4,229
NASDAQ SERA Sera Prognostics
Harrison Robert Gardner / officer: Chief Information Officer
01/10/2025
Sell
$7.30
12,372
$90K
118,674
NASDAQ SERA Sera Prognostics
Phillips Joshua / director
01/13/2025
Sell
$6.39
3
$19
2
NASDAQ SERA Sera Prognostics
Phillips Joshua / director
01/10/2025
Sell
$7.18
4,896
$35K
12,788
NASDAQ SERA Sera Prognostics
Aerts Austin / officer: Chief Financial Officer
01/10/2025
Sell
$8.06
2,431
$20K
283,325
NASDAQ SERA Sera Prognostics
Phillips Joshua / director
01/13/2025
Sell
$6.39
6,287
$40K
4,827
NASDAQ SERA Sera Prognostics
Jackson Benjamin / officer: General Counsel
01/14/2025
Sell
$6.20
8,407
$52K
112,154
NASDAQ SERA Sera Prognostics
Phillips Joshua / director
01/10/2025
Sell
$8.03
1
$8
5
NASDAQ SGHT Sight Sciences
HAYDEN JEREMY B. / officer: Chief Legal Officer
01/17/2025
Sell
$2.78
6,922
$19K
145,091
NASDAQ SGHT Sight Sciences
Badawi Paul / director, officer: President and CEO
01/16/2025
Sell
$2.92
24,819
$73K
5.68M
NASDAQ SGHT Sight Sciences
Badawi David / director, officer: Chief Technology Officer
01/17/2025
Sell
$2.78
5,423
$15K
1.74M
NASDAQ STAA STAAR Surgical
BROADWOOD PARTNERS, L.P. / 10 percent owner
01/14/2025
Buy
$21.46
21,155
$454K
10.87M
NASDAQ STAA STAAR Surgical
BROADWOOD PARTNERS, L.P. / 10 percent owner
01/16/2025
Buy
$21.50
8,221
$177K
10.88M
NASDAQ TYRA Tyra Biosciences
Kjellson Nina S / director
01/17/2025
Sell
$16.40
461
$8K
447,396
NASDAQ TYRA Tyra Biosciences
Kjellson Nina S / director
01/16/2025
Sell
$16.29
835
$14K
447,857
NASDAQ TYRA Tyra Biosciences
Kjellson Nina S / director
01/21/2025
Sell
$16.36
3,993
$65K
3.71M
NASDAQ TYRA Tyra Biosciences
Kjellson Nina S / director
01/17/2025
Sell
$16.40
12,808
$210K
3.71M
NASDAQ TYRA Tyra Biosciences
Kjellson Nina S / director
01/16/2025
Sell
$16.29
6,944
$113K
3.72M
NASDAQ VYGR Voyager Therapeutics
Carter Todd Alfred / officer: Chief Scientific Officer
01/14/2025
Sell
$5.13
1,191
$6K
86,436
NASDAQ VYGR Voyager Therapeutics
Swartz Robin / officer: COO & CBO
01/14/2025
Sell
$5.09
3,087
$16K
109,241
NASDAQ VYNE VYNE Therapeutics
LEPORE PATRICK G / director
01/15/2025
Buy
$2.92
15,000
$44K
51,472
NASDAQ ZYME Zymeworks
EcoR1 Capital, LLC / director, 10 percent owner:
01/16/2025
Buy
$13.89
121,681
$1.690M
15.70M
NASDAQ ZYME Zymeworks
EcoR1 Capital, LLC / director, 10 percent owner:
01/17/2025
Buy
$13.87
19,748
$274K
15.72M

  Research Tools
  News & Announcements
  Popular Topics
  Miscellaneous